Our investments encompass later stage venture, growth capital and recapitalizations.
Along with seasoned management and founders, we emphasize proven technology and business models across these investment stages.
Our venture investments focus on medical devices, technology-enabled services and purpose-built applications targeting niche markets. We seek businesses with an unfair advantage and the potential to be disruptive.
By contrast, our growth equity and recapitalization investments target more mature companies and expand beyond this core focus to include selective asset-light consumer companies.
Our investments range from $1M-$5M in venture stage deals to $10-20M+ in growth equity and recapitalizations.